Request Deal Involvement
Ares Life Sciences and Waypoint completed acquisition of Stallergenes Greer for $134m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
FTI Consulting
pr advisors
Havas
financial advisors
Evercore
legal advisors
Clifford Chance
legal advisors
Jones Day
accounting advisors
Finexsi
financial advisors
UBS
pr advisors
Hirzel Neef Schmid Konsulenten
legal advisors
Skadden Arps Slate Meagher & Flom
or
Principals
target
STALLERGENES GREER
bidder
ARES LIFE SCIENCES
bidder
WAYPOINT CAPITAL
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite